Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
Clinical Pharmacology and Therapeutics
|
December 16, 2017
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status
Paul G Baverel, Vincent F S Dubois, Chao Yu Jin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 24, 2023
Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study
Zhongyin Yang, Sheng Lu, Min Shi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2020
Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial
Yanan Zheng, Xiao Yang, Chao Yan, et al.
The Journal of Infectious Diseases
|
April 3, 2025
Lenacapavir Plus Two Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab
Joseph J Eron, Paul P Cook, Megha L Mehrotra, et al.
British Journal of Clinical Pharmacology
|
December 1, 2022
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance
Michael Hwang, Yen Lin Chia, Yanan Zheng, et al.
American Journal of Translational Research
|
April 12, 2021
Prediction model of objective response after neoadjuvant chemotherapy in patients with locally advanced gastric cancer
Wei Xu, Zhiyuan Fan, Lingquan Wang, et al.
Frontiers in Oncology
|
May 3, 2021
Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
Wei Xu, Qianchen Ma, Lingquan Wang, et al.
Clinical Lung Cancer
|
July 23, 2019
Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients
Sriram Sridhar, Luis Paz-Ares, Hao Liu, et al.
Frontiers in Oncology
|
September 20, 2021
Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
Wei Xu, Wentao Liu, Lingquan Wang, et al.
Frontiers in Oncology
|
September 9, 2021
Neoadjuvant Chemotherapy <i>Versus</i> Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
Wei Xu, Lingquan Wang, Chao Yan, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
Clinical Pharmacology and Therapeutics
|
December 16, 2017
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status
Paul G Baverel, Vincent F S Dubois, Chao Yu Jin, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
December 24, 2023
Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study
Zhongyin Yang, Sheng Lu, Min Shi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2020
Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial
Yanan Zheng, Xiao Yang, Chao Yan, et al.
The Journal of Infectious Diseases
|
April 3, 2025
Lenacapavir Plus Two Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab
Joseph J Eron, Paul P Cook, Megha L Mehrotra, et al.
British Journal of Clinical Pharmacology
|
December 1, 2022
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance
Michael Hwang, Yen Lin Chia, Yanan Zheng, et al.
American Journal of Translational Research
|
April 12, 2021
Prediction model of objective response after neoadjuvant chemotherapy in patients with locally advanced gastric cancer
Wei Xu, Zhiyuan Fan, Lingquan Wang, et al.
Frontiers in Oncology
|
May 3, 2021
Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
Wei Xu, Qianchen Ma, Lingquan Wang, et al.
Clinical Lung Cancer
|
July 23, 2019
Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients
Sriram Sridhar, Luis Paz-Ares, Hao Liu, et al.
Frontiers in Oncology
|
September 20, 2021
Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
Wei Xu, Wentao Liu, Lingquan Wang, et al.
Frontiers in Oncology
|
September 9, 2021
Neoadjuvant Chemotherapy <i>Versus</i> Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
Wei Xu, Lingquan Wang, Chao Yan, et al.
Page
of 13